Publications by authors named "A Agulnick"

LIM homeodomain factors regulate the development of many cell types. However, transcriptional coactivators that mediate their developmental function remain poorly defined. To address these, we examined how two related NLI-dependent LIM complexes, which govern the development of spinal motor neurons and V2a interneurons, activate the transcription in the embryonic spinal cord.

View Article and Find Full Text PDF

Unlabelled: The PEC-01 cell population, differentiated from human embryonic stem cells (hESCs), contains pancreatic progenitors (PPs) that, when loaded into macroencapsulation devices (to produce the VC-01 candidate product) and transplanted into mice, can mature into glucose-responsive insulin-secreting cells and other pancreatic endocrine cells involved in glucose metabolism. We modified the protocol for making PEC-01 cells such that 73%-80% of the cell population consisted of PDX1-positive (PDX1+) and NKX6.1+ PPs.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on developing a scalable and regulated manufacturing process for creating pancreatic progenitors from human embryonic stem cells (hESC) to treat type 1 diabetes.
  • Researchers optimized methods for expanding and differentiating the CyT49 cell line, resulting in a resource that can produce functional insulin-secreting cells in a controlled environment.
  • Upon implantation into mice, these cells formed mature pancreatic tissue that effectively managed glucose levels, indicating progress toward a potential clinical therapy for diabetes.
View Article and Find Full Text PDF

SSBP proteins bind and stabilize transcriptional cofactor LIM domain-binding protein1 (LDB1) from proteosomal degradation to promote tissue-specific transcription through an evolutionarily conserved pathway. The human SSBP2 gene was isolated as a candidate tumor suppressor from a critical region of loss in chromosome 5q14.1.

View Article and Find Full Text PDF
Article Synopsis
  • Development of a cell therapy for diabetes can be enhanced by a continuous source of human beta-cells, and research shows that pancreatic endoderm from human embryonic stem (hES) cells can generate these cells effectively.
  • When implanted in mice, these cells responded to glucose by producing human insulin and C-peptide at levels comparable to natural human islets.
  • Additionally, the implanted cells demonstrated key characteristics of functional beta-cells and were able to protect against high blood sugar levels induced by streptozotocin, confirming the potential of hES cells for diabetes treatment.
View Article and Find Full Text PDF